A detailed history of Allianz Asset Management Gmb H transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 26,833 shares of BMRN stock, worth $1.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,833
Previous 26,888 0.2%
Holding current value
$1.7 Million
Previous $2.21 Million 14.78%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$69.02 - $93.84 $3,796 - $5,161
-55 Reduced 0.2%
26,833 $1.89 Million
Q2 2024

Aug 13, 2024

BUY
$74.43 - $92.22 $396,711 - $491,532
5,330 Added 24.72%
26,888 $2.21 Million
Q1 2024

May 13, 2024

SELL
$83.81 - $99.0 $1.38 Million - $1.63 Million
-16,486 Reduced 43.33%
21,558 $1.88 Million
Q4 2023

Feb 12, 2024

SELL
$76.22 - $98.51 $518,829 - $670,557
-6,807 Reduced 15.18%
38,044 $3.67 Million
Q3 2023

Nov 13, 2023

SELL
$85.07 - $94.48 $240,918 - $267,567
-2,832 Reduced 5.94%
44,851 $3.97 Million
Q2 2023

Aug 11, 2023

BUY
$86.68 - $100.3 $94,654 - $109,527
1,092 Added 2.34%
47,683 $4.13 Million
Q1 2023

May 11, 2023

BUY
$87.74 - $117.27 $2,018 - $2,697
23 Added 0.05%
46,591 $4.53 Million
Q4 2022

Feb 13, 2023

SELL
$80.93 - $108.63 $233,563 - $313,506
-2,886 Reduced 5.84%
46,568 $4.82 Million
Q3 2022

Nov 08, 2022

SELL
$82.16 - $96.94 $3.7 Million - $4.37 Million
-45,053 Reduced 47.67%
49,454 $4.19 Million
Q2 2022

Aug 12, 2022

BUY
$71.48 - $86.85 $1.97 Million - $2.39 Million
27,559 Added 41.16%
94,507 $7.83 Million
Q1 2022

May 13, 2022

BUY
$74.28 - $92.69 $5,125 - $6,395
69 Added 0.1%
66,948 $5.16 Million
Q4 2021

Feb 11, 2022

BUY
$71.72 - $91.47 $425,299 - $542,417
5,930 Added 9.73%
66,879 $5.92 Million
Q3 2021

Nov 10, 2021

BUY
$74.77 - $85.47 $510,828 - $583,931
6,832 Added 12.62%
60,949 $4.71 Million
Q2 2021

Aug 16, 2021

SELL
$75.51 - $84.79 $16.3 Million - $18.3 Million
-215,347 Reduced 79.92%
54,117 $4.52 Million
Q1 2021

May 13, 2021

SELL
$74.73 - $90.69 $1.71 Million - $2.08 Million
-22,900 Reduced 7.83%
269,464 $20.3 Million
Q4 2020

Feb 16, 2021

BUY
$72.61 - $90.2 $6.96 Million - $8.64 Million
95,801 Added 48.74%
292,364 $25.6 Million
Q3 2020

Nov 13, 2020

SELL
$71.87 - $131.03 $11.8 Million - $21.5 Million
-164,040 Reduced 45.49%
196,563 $15 Million
Q2 2020

Aug 14, 2020

BUY
$79.55 - $124.22 $5.07 Million - $7.92 Million
63,737 Added 21.47%
360,603 $44.5 Million
Q1 2020

May 14, 2020

SELL
$71.37 - $96.85 $4.39 Million - $5.96 Million
-61,578 Reduced 17.18%
296,866 $25.1 Million
Q4 2019

Feb 13, 2020

SELL
$64.27 - $86.37 $8.51 Million - $11.4 Million
-132,434 Reduced 26.98%
358,444 $30.3 Million
Q3 2019

Nov 13, 2019

BUY
$67.4 - $85.11 $264,477 - $333,971
3,924 Added 0.81%
490,878 $33.1 Million
Q2 2019

Aug 08, 2019

SELL
$80.35 - $93.9 $3.84 Million - $4.49 Million
-47,853 Reduced 8.95%
486,954 $41.7 Million
Q1 2019

May 13, 2019

BUY
$84.2 - $98.62 $2.1 Million - $2.46 Million
24,984 Added 4.9%
534,807 $47.5 Million
Q4 2018

Feb 14, 2019

BUY
$80.14 - $106.07 $3.01 Million - $3.98 Million
37,560 Added 7.95%
509,823 $43.3 Million
Q3 2018

Nov 13, 2018

BUY
$93.92 - $105.72 $1.4 Million - $1.58 Million
14,912 Added 3.26%
472,263 $45.8 Million
Q2 2018

Aug 13, 2018

BUY
$76.01 - $99.03 $953,317 - $1.24 Million
12,542 Added 2.82%
457,351 $43.1 Million
Q1 2018

May 14, 2018

SELL
$77.67 - $92.63 $988,428 - $1.18 Million
-12,726 Reduced 2.78%
444,809 $36.1 Million
Q4 2017

Feb 13, 2018

SELL
$80.76 - $95.13 $646,080 - $761,040
-8,000 Reduced 1.72%
457,535 $40.8 Million
Q3 2017

Nov 13, 2017

SELL
$80.6 - $94.95 $8.46 Million - $9.97 Million
-104,981 Reduced 18.4%
465,535 $43.3 Million
Q2 2017

Aug 14, 2017

SELL
N/A
-41,014 Reduced 6.71%
570,516 $51.6 Million
Q1 2017

Apr 17, 2019

BUY
N/A
37,162 Added 6.47%
611,530 $53.8 Million
Q4 2016

Apr 17, 2019

SELL
N/A
-59,246 Reduced 9.35%
574,368 $47.6 Million
Q3 2016

Apr 17, 2019

BUY
N/A
633,614
633,614 $58.7 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.8B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.